Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
12:00:00 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5,764.00 JPY | -1.05% |
|
+2.73% | +19.21% |
| 20/08 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 18/08 | Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading | MT |
| Market Cap | 9,30100Cr 5.86TCr 5.02TCr 4.68TCr 4.29TCr 8.07TCr 5,60600Cr 8.23TCr 56TCr 22TCr 2,80900Cr 22TCr 22TCr | P/E 2027 * |
47.5x | P/E 2028 * | 30.4x |
|---|---|---|---|---|---|
| Enterprise Value | 13,20300Cr 8.32TCr 7.12TCr 6.64TCr 6.1TCr 11TCr 7,95800Cr 12TCr 79TCr 31TCr 3,98800Cr 31TCr 31TCr | EV / Sales 2027 * |
2.82x | EV / Sales 2028 * | 2.73x |
| Free-Float |
99.25% | Yield 2027 * |
3.51% | Yield 2028 * | 3.58% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.05% | ||
| 1 week | +2.73% | ||
| Current month | +4.55% | ||
| 1 month | +3.76% | ||
| 3 months | +11.27% | ||
| 6 months | -0.93% | ||
| Current year | +19.21% |
| 1 week | 5,504 |  | 5,840 |
| 1 month | 5,225 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/08/26 | Sell | Head of Human Resources | -12,980 | 0.0008% | ||
| 11/08/26 | Sell | Pres., Global Supply & Quality | -20,363 | 0.0013% | ||
| 10/08/26 | Sell | Pres., Global Supply & Quality | -3,978 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +2.73% | +27.16% | +31.36% | 5.86TCr | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,10900Cr | |
| -2.21% | +2.02% | +49.50% | +55.01% | 64TCr | |
| -1.56% | +4.39% | +25.19% | +74.39% | 46TCr | |
| -1.22% | +3.27% | +39.70% | +44.20% | 37TCr | |
| -0.89% | +2.17% | +21.62% | +39.00% | 30TCr | |
| -1.01% | +4.30% | -0.79% | +11.98% | 26TCr | |
| -1.95% | +3.80% | +46.31% | +65.66% | 23TCr | |
| -0.25% | +0.22% | -17.06% | -53.16% | 20TCr | |
| -2.82% | +3.84% | +20.81% | +89.04% | 18TCr | |
| Average | -1.58% | +3.18% | +28.88% | +48.52% | 38.2TCr | |
| Weighted average by Cap. | -1.91% | +3.28% | +42.41% | +69.36% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,68400Cr 2.95TCr 2.53TCr 2.36TCr 2.16TCr 4.06TCr 2,82300Cr 4.14TCr 28TCr 11TCr 1,41500Cr 11TCr 11TCr | 4,75800Cr 3TCr 2.57TCr 2.39TCr 2.2TCr 4.13TCr 2,86800Cr 4.21TCr 28TCr 11TCr 1,43700Cr 11TCr 11TCr |
| Net income | 19TCr 120.11Cr 102.83Cr 96Cr 88Cr 165.43Cr 11TCr 168.69Cr 1.14TCr 443.71Cr 5.76TCr 450.97Cr 441.16Cr | 31TCr 197.18Cr 168.83Cr 157.52Cr 144.54Cr 271.6Cr 19TCr 276.94Cr 1.87TCr 728.45Cr 9.46TCr 740.38Cr 724.27Cr |
| Net Debt | 3,90200Cr 2.46TCr 2.1TCr 1.96TCr 1.8TCr 3.39TCr 2,35200Cr 3.45TCr 23TCr 9.08TCr 1,17900Cr 9.23TCr 9.03TCr | 3,70100Cr 2.33TCr 2TCr 1.86TCr 1.71TCr 3.21TCr 2,23100Cr 3.27TCr 22TCr 8.61TCr 1,11800Cr 8.75TCr 8.56TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | JP¥5,764.00 | -1.05% | 31,77,000 |
| 20/26/20 | JP¥5,825.00 | +0.97% | 52,68,300 |
| 19/26/19 | JP¥5,769.00 | +1.18% | 67,79,900 |
| 18/26/18 | JP¥5,702.00 | +3.43% | 46,55,200 |
| 17/26/17 | JP¥5,513.00 | -1.75% | 25,29,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
